Since the introduction to the Swiss market in 1997, Crucell (former Berna Biotech Ltd.), has
sold over 41 million doses worldwide of the virosomal adjuvanted influenza vaccine …

An international panel of experts prepared an evidenced-based guideline for vaccination of
immunocompromised adults and children. These guidelines are intended for use by primary …

No official recommendations have been made on whether children infected with HIV on
highly active antiretroviral therapy (HAART) should be revaccinated. We reviewed published …

Only limited data are available regarding the immunogenicity of the BNT162b2 mRNA
vaccine in HIV-1+ patients. Therefore, we investigated the humoral immune response after …

Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …

Human immunodeficiency virus (HIV) replication causes lymphoid tissue (LT) fibrosis, which
causes CD4+ T-cell depletion. It is unknown whether people who spontaneously control HIV …

Background Influenza infection in HIV-infected individuals is associated with increased
severity of illness. We performed a systematic review of the available evidence on efficacy …

Protecting HIV-positive patients against vaccine-preventable infections is important now that
HAART has restored life expectancy and general well being, and increased the likelihood of …

This study seeks to assess the ability of seasonal trivalent inactivated influenza vaccine (TIV)
to induce nonneutralizing antibodies (Abs) with Fc-mediated functions in HIV-uninfected and …

Background Children born to HIV+ mothers are exposed intra-utero to several drugs and
cytokines that can modify the developing immune system, and influence the newborn's …